520
Participants
Start Date
July 30, 2019
Primary Completion Date
July 27, 2021
Study Completion Date
March 11, 2022
Galcanezumab
Administered SC
Placebo
Administered SC
Shanghai East Hospital, Shanghai
HuaShan Hospital Affiliated To Fudan University, Shanghai
Xuanwu Hospital-Capital Medical University, Beijing
Chinese PLA General Hospital, Beijing
Gobind Ballabh Pant Hospital, New Delhi
All India Institute of Medical Sciences, New Delhi
Sir Ganga Ram Hospital, New Delhi
First Moscow State Medical University n.a. Sechenov, Moscow
University Headache Clinic, Moscow
Artemis Hospital, Gurgaon
No.2 Hospital Affiliated to Jilin University, Changchun
Academician I.P. Pavlov First St-Petersburg State Medical University, Saint Petersburg
Zhongshan Hospital, Fudan University, Shanghai
Jiangsu Province Hospital, Nanjing
Affiliated Hospital of Jiangsu University, Zhenjiang
The First Affliated Hospital of Soochow University, Suzhou
Jinan Central Hospital, Jinan
People's hospital of Rizhao, Rizhao
Tianjin Medical University General Hospital, Tianjin
Tianjin Huanhu Hospital, Tianjin
Zhejiang Hospital, Hangzhou
Pingxiang People's Hospital, Pingxiang
Apollo Hospitals International Ltd., Ahmedabad
The First Affiliated Hospital Chongqing Medical University, Chongqing
Xiangya Hospital, Central South University, Changsha
Deenanath Mangeshkar Hospital & Research Centre, Pune
HCG Manavata Cancer Centre, Nashik
Wuhan Union Hospital, Wuhan
Tongji Hosp Tongji Med Col Huazhong Univ of Sci & Tech, Wuhan
Getwell Hospital & Research Institute, Nagpur
The First Affiliated Hospital of Zhengzhou Universtiy, Zhengzhou
CHL - Apollo Hospital, Indore
Guangzhou First People's Hospital, Guangzhou
The Affiliated Hospital of Guiyang Medical College, Guiyang
Mangala Hospitals & Mangala Kidney Foundation, Mangalore
"OOO Medis", Nizhny Novgorod
West China Hospital Sichuan University, Chengdu
First Affiliated Hospital of Kunming Medical University, Kunming
First Affiliated Hospital of Xi'an Jiaotong University, Xi'an
Bao Tou Central Hospital, Baotou
Eli Lilly and Company
INDUSTRY